Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach
- 24 July 2003
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 43 (2) , 118-126
Abstract
Aims: Whether immunohistochemical markers increase accuracy in predicting prognosis for gastrointestinal stromal tumours (GISTs) remains uncertain. However, past studies have used only small, heterogeneous patient groups. Our aim was to test previously studied and more novel morphological features as well as four immunohistochemical markers as prognostic indicators amongst a large cohort of surgically resected, gastric GISTs.Methods and results: Tissues from 127 gastric mesenchymal tumours were collected retrospectively and subjected to repeat histological assessment and immunophenotyping. Further immunohistochemistry was performed for Ki67, p53, Bcl‐2 and cyclin D1. Complete follow‐up data were collected for 108 patients with immunophenotyped diagnoses of GIST (i.e. c‐kit+ tumours). At the census point, 52 patients were alive, 24 had died from their GISTs and the remainder of other causes. Univariate analysis showed the following predicted for shorter disease‐specific survival: size ≥50 mm; necrosis, no intratumoral lymphocytes; mitotic count ≥5/50 high power fields; Ki67 labelling index ≥5%; p53 immunopositivity. Of these variables, multivariate analyses showed only mitotic count and, to a lesser extent, Ki67 labelling to be independent prognostic indicators.Conclusions: Mitotic count remains the best predictor of outcome following surgical resection of gastric GISTs. Ki67 immunohistochemistry does not provide better prognostication and p53, Bcl‐2 and cyclin D1 immunohistochemistry provide no additional prognostication.Keywords
This publication has 34 references indexed in Scilit:
- Molecular characterisation of soft tissue tumours: a gene expression studyThe Lancet, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Ki67 protein: the immaculate deception?Histopathology, 2002
- The Effect of Surgery and Grade on Outcome of Gastrointestinal Stromal TumorsArchives of Surgery, 2001
- Predicting Metastatic Risk of Gastrointestinal Stromal Tumors: Role of Cell Proliferation and Cell Cycle Regulatory ProteinsInternational Journal of Surgical Pathology, 2000
- Prognosis of Gastrointestinal Smooth-Muscle (Stromal) TumorsAmerican Journal of Surgical Pathology, 1999
- The inhibitors of apoptosis (IAPs) and their emerging role in cancerOncogene, 1998
- Stromal Tumors of the Duodenum A Histologic and Immunohistochemical Study of 20 CasesAmerican Journal of Surgical Pathology, 1995
- Gastrointestinal stromal tumours: Correlation of immunophenotype with clinicopathological featuresThe Journal of Pathology, 1991
- Smooth Muscle Tumors of the Gastrointestinal TractAmerican Journal of Surgical Pathology, 1988